Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Diagnostics, 2026

Graph Neural Network Modelling of Pre-Diagnostic Serum Proteomics for Pancreatic Cancer Detection

Zaikin A., Gentry-Maharaj A., Apostolidou S. et al.

Current Oncology, 2026

Olink Platform-Based Identification of Peripheral Blood Biomarkers for irAEs in Advanced NSCLC

Zhang Z., Chen B., Jiang H. et al.

Aging Cell, 2026

Birthweight and Breastfeeding Shape Patterns of Biological Aging Across Adult Organs

Wei W., Qi X., Cheng B. et al.

Journal of Affective Disorders, 2026

Cardiorespiratory fitness and risk of depression and anxiety: A prospective cohort study with proteomic profiling in the UK Biobank

Liu Y., Li Y., Liu X. et al.

Leukemia, 2026

Generation of a novel knock-in mouse line expressing oncogenic Kit D814V in the hematopoietic stem cell compartment as a preclinical model for systemic mastocytosis

Stivala S., Makeeva A., Almeida Fonseca T. et al.

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2026

Impact of treatment mechanism on octave MSDA pathway scores in patients receiving ocrelizumab or natalizumab

Heidari H., Maghbooli Z., Zabeti A.

Bioorganic Chemistry, 2026

A natural product-derived degrader (COT-01): cortisone-based CRBN recruitment for cyclin D2 degradation in multiple myeloma

Lee S., Kim S., Lee K. et al.

npj Digital Medicine, 2026

A generalizable biopsychosocial risk score for stratifying disease vulnerability in healthy populations

Chen J., Chu C., Garcia-Argibay M. et al.

Genomics, Proteomics & Bioinformatics, 2026

Distinct Genetic Determinants of Plasma Inflammatory Proteins in Tanzanian and Dutch Populations

Amour C., Boahen C., Temba G. et al.

Molecular Medicine, 2026

CD248 expression in human adipose tissue is upregulated in obesity and following glucocorticoid exposure: a mediator of insulin resistance and adipose dysfunction?

Laterveer R., Lundqvist M., Conway E. et al.

Nature Communications, 2026

Clonal haematopoiesis subtypes confer dose-dependent risk of serious bacterial infection

Fewings E., Yu Z., Gutierrez J. et al.

Aging Cell, 2026

Chronic Senolytic Treatment and/or Aerobic Exercise Reduce Senescence and Improve Myocardial Function During Aging in the Heart

Bevington R., Johnson A., Hockey B. et al.

Experimental Gerontology, 2026

Perceived psychosocial stressors and inflammatory biomarkers among urban-dwelling older Black adults

Adeola H., Yaskolka Meir A., Tasaki S. et al.

Clinical and Translational Medicine, 2026

A serum proteomics‐based predictive model for steroid‐resistant immune checkpoint inhibitor associated myocarditis

Zhang Y., Li Y., Zhang J. et al.

Clinical & Experimental Allergy, 2026

Chronic Spontaneous Urticaria Endotypes: Exploratory Proteomic Analysis in the Benralizumab ARROYO Study

Rodríguez‐Suárez E., Cardner M., Muthas D. et al.

Frontiers in Immunology, 2026

APASL-ACLF without previous decompensation is immunologically distinct from EASL-CLIF-ACLF with previous decompensation

Langer M., Weiss M., Bauschen A. et al.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2026

Immunomodulatory effects of lithium treatment in bipolar disorder: A prospective cohort study

Ponzer K., Bektash B., Lundberg M. et al.

The Journal of Infectious Diseases, 2026

Plasma Proteome Signature of Immune Inhibition Is Associated With Cytomegalovirus in People With HIV-1

Freeman M., Honerkamp-Smith G., Wells A. et al.

MedComm, 2026

Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2‐Low Breast Cancer

Liu X., Song Y., Liu L. et al.

The Ocular Surface, 2026

Efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease: a prospective, blinded, randomized, crossover study

Roels D., van Gremberghe I., Huys L. et al.

4626 publications